BlackRock Group’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $145K | Buy |
7,007
+609
| +10% | +$12.6K | ﹤0.01% | 2737 |
|
|
2016
Q3 | $104K | Buy |
6,398
+261
| +4% | +$4.24K | ﹤0.01% | 2798 |
|
|
2016
Q2 | $84K | Sell |
6,137
-87
| -1% | -$1.19K | ﹤0.01% | 2820 |
|
|
2016
Q1 | $108K | Buy |
6,224
+2,650
| +74% | +$46K | ﹤0.01% | 2726 |
|
|
2015
Q4 | $122K | Sell |
3,574
-117
| -3% | -$3.99K | ﹤0.01% | 2616 |
|
|
2015
Q3 | $110K | Buy |
3,691
+982
| +36% | +$29.3K | ﹤0.01% | 2670 |
|
|
2015
Q2 | $87K | Buy |
+2,709
| New | +$87K | ﹤0.01% | 2766 |
|
|
2015
Q1 | – | Sell |
-626
| Closed | -$11K | – | 2883 |
|
|
2014
Q4 | $11K | Hold |
626
| – | – | ﹤0.01% | 2841 |
|
|
2014
Q3 | $12K | Hold |
626
| – | – | ﹤0.01% | 2778 |
|
|
2014
Q2 | $21K | Buy |
+626
| New | +$21K | ﹤0.01% | 2737 |
|